The safety and efficacy of iberdomide for the treatment of multiple myeloma

Iberdomide – efficacy and safety in RRMMПодробнее

Real-world safety and efficacy of talquetamab for the treatment of R/R myelomaПодробнее

Results of Iberdomide in Combination with Dex and Daratumumab or Bortezomib in Patients with RRMMПодробнее

The safety and efficacy of elotuzumab for the treatment of multiple myelomaПодробнее

Safety and efficacy of iberdomide + dexamethasone in patients with triple-class refractory myelomaПодробнее

The efficacy & role of iberdomide in R/R multiple myelomaПодробнее

2019 Multiple Myeloma Symposium | Novel and Next Generation TherapyПодробнее

Results from the MajesTEC-2 and TRIMM-2 Clinical Trials for Patients With Multiple MyelomaПодробнее

Evaluating the safety and efficacy of elranatamab in multiple myelomaПодробнее

Update on iberdomide treatment combinations in R/R myelomaПодробнее

Real-world safety and efficacy of cilta-cel in R/R multiple myelomaПодробнее

Iberdomide in Combination with Dex and Dara, Bort, or Cfz in Pts with RRMMПодробнее

Iberdomide plus dexamethasone for heavily pretreated multiple myelomaПодробнее

Safety and Efficacy of Multiantigen-Targeted T Cells for Multiple MyelomaПодробнее

A Phase I/II trial of iberdomide for the treatment of intermediate- or high-risk smoldering myelomaПодробнее

The safety and efficacy of selinexor for the treatment of myelomaПодробнее

Real-world efficacy and safety of selinexor in R/R multiple myelomaПодробнее

How might the iberdomide safety profile be critical for its future applications?Подробнее

Iberdomide + dexamethasone in R/R multiple myelomaПодробнее

Safety and Efficacy: ElotuzumabПодробнее